Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 7/20 | 1.00 |
| ▸ | CHRNA4 | P43681 | 7/20 | 1.00 |
| ▸ | CHRNA7 | P36544 | 4/20 | 1.00 |
| ▸ | CHRNB4 | P30926 | 4/20 | 1.00 |
| ▸ | CHRNA3 | P32297 | 4/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | CHRNA2 | Q15822 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | CHRNA1 | P02708 | 1/20 | 1.00 |
| ▸ | CHRNG | P07510 | 1/20 | 1.00 |
| ▸ | CHRNB1 | P11230 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | CHRND | Q07001 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Epibatidine SCHEMBL316978 | 1.00 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3 | |
| (-)-Epibatidine SCHEMBL2500147 | 1.00 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3 | |
| Epibatidine SCHEMBL9070584 | 1.00 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3 | |
| Epibatidine SCHEMBL29390446 | 1.00 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3 | |
| (+)-Epibatidine SCHEMBL5267259 | 0.98 | CHRNA7 (1.00) | CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3 | |
| (+)-Epibatidine SCHEMBL6264689 | 0.98 | CHRNB2 (0.97) | CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3 | |
| Epibatidine SCHEMBL5969577 | 0.98 | CHRNA7 (1.00) | CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3 | |
| Homoepibatidine SCHEMBL29711361 | 0.91 | CHRNB2 (1.00) | CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3 | |
| SCHEMBL7663147 | 0.84 | CHRNB2 (0.72) | CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3 | |
| SCHEMBL13596272 | 0.84 | CHRNB2 (0.72) | CHRNB2CHRNA4CHRNA7CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2447 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| WO-2025037323-A1 | PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF DRY EYE DISEASE AND ASSOCIATED DISORDERS | KOTHAPUVARI PAVAN KUMAR (IN) | 2025-02-20 | — | — | WO | claimed |
| WO-2025027196-A1 | A METHOD OF PRODUCING NANOPARTICLES OF A DEFINED SIZE | IQ MEDICAL GMBH (DE) | 2025-02-06 | — | — | WO | claimed |
| WO-2025027194-A1 | A METHOD OF PREPARING AN AQUEOUS DISPERSION OF NANOPARTICLES | IQ MEDICAL GMBH (DE) | 2025-02-06 | — | — | WO | claimed |
| EP-4501320-A1 | A METHOD OF PREPARING AN AQUEOUS DISPERSION OF NANOPARTICLES | IQ medical GmbH (DE) | 2025-02-05 | — | — | EP | claimed |
| US-20250032503-A1 | USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASE | HOTH THERAPEUTICS, INC. | 2025-01-30 | — | — | US | claimed |
| US-20240329053-A1 | A CELL-BASED METHOD FOR DETECTING POTENTIALLY PATHOGENIC AUTOANTIBODIES TO NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS | TZARTOS NEURODIAGNOSTICS (GR) | 2024-10-03 | — | — | US | claimed |
| US-20240173318-A1 | DRY EYE TREATMENTS | OYSTER POINT PHARMA INC (US) | 2024-05-30 | — | — | US | claimed |
| EP-4297868-A1 | USE OF APREPITANT FOR TREATING ALZHEIMER'S DISEASE | Hoth Therapeutics, Inc. (US) | 2024-01-03 | — | — | EP | claimed |
| WO-2023212244-A1 | METHODS OF TREATING 5HT2A RECEPTOR-MEDIATED CONDITIONS | TESSELLATE THERAPEUTICS, INC. (US) | 2023-11-02 | — | — | WO | claimed |
| WO-2001058951-A2 | WATER-SOLUBLE LIGAND-BINDING PROTEINS OF LIGAND-GATED ION CHANNELS, CRYSTALS THEREOF AND THEIR USE FOR SCREENING LIGANDS OF LIGAND-GATED ION CHANNELS | STICHTING VOOR DE TECHNISCHE WETENSCHAPPEN (NL) | 2001-08-16 | — | — | WO | claimed |
| US-6252132-B1 | Mutant mouse containing a knockout mutation in DNA encoding an endogenous alpha 4 subunit of nicotinic acetylcholine receptor | INSTITUT PASTEUR (FR) | 2001-06-26 | — | — | US | claimed |
| WO-2000045846-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING NICOTINE OR A LIGAND OF NICOTINE RECEPTORS AND A MONAMINE OXYDASE INHIBITOR AND THEIR USE FOR TREATING TOBACCO WITHDRAWAL SYMPTOMS | SANOFI-SYNTHELABO (FR) | 2000-08-10 | — | — | WO | claimed |
| WO-2000026392-A2 | MUTANT MOUSE CONTAINING A KNOCKOUT MUTATION IN DNA ENCODING AN ENDOGENOUS α4 SUBUNIT OF NICOTINIC ACETYLCHOLINE RECEPTOR | INSTITUT PASTEUR (FR) | 2000-05-11 | — | — | WO | claimed |
| EP-0657456-B1 | Process for preparing epibatidine | EGYT GYOGYSZERVEGYESZETI GYAR (HU) | 1997-06-04 | — | — | EP | claimed |
| US-5565573-A | Synthesis of epibatidine and analogs thereof | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1996-10-15 | — | — | US | claimed |
| EP-0736534-A1 | Process for preparing epibatidine | EGIS GYOGYSZERGYAR RT. (HU) | 1996-10-09 | — | — | EP | claimed |
| US-5545741-A | Process for the preparation of epibatidine | EGIS GYOGYSZERGYAR RT. (HU) | 1996-08-13 | — | — | US | claimed |
| US-5510490-A | Process for the preparation of epibatidine | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 1996-04-23 | — | — | US | claimed |
| EP-0657456-A1 | Process for preparing epibatidine | EGIS GYOGYSZERGYAR RT. (HU) | 1995-06-14 | — | — | EP | claimed |